|
"yu yun shao"的相关文件
显示项目 101-110 / 113 (共12页)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2019 |
Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management
|
O'Brien T.; Ahn J.S.; Chye R.; Le B.; Lu H.; Olarte G.; Palladini M.; Salti A.; YU-YUN SHAO; Yaakup H.; Buemio K.C.; Colin C.G.; Hadjiat Y.; O'Brien T.;Ahn J.S.;Chye R.;Le B.;Lu H.;Olarte G.;Palladini M.;Salti A.;Yu-Yun Shao;Yaakup H.;Buemio K.C.;Colin C.G.;Hadjiat Y. |
| 臺大學術典藏 |
2018-09-10T14:53:05Z |
Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases
|
Shao, Y.-Y. and Ho, M.-C. and Cheng, A.-L. and Hsu, C.-H.; Shao, Yu-Yun;Ho, Ming-Chih;Cheng, Ann-Lii;Hsu, Chih-Hung; 邵幼雲;鄭安理;徐志宏;何明志; 邵幼雲;鄭安理;徐志宏;何明志; Shao, Yu-Yun; Shao, Yu-Yun; MING-CHIH HO; CHIH-HUNG HSU; Ho, Ming-Chih; Ho, Ming-Chih; Cheng, Ann-Lii; Yu-Yun Shao; Hsu, Chih-Hung; ANN-LII CHENG; Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T14:51:53Z |
beta-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma
|
高祥豐;邵幼雲;鄭安理;徐志宏;呂理駿;謝明書;李宜軒; Lu, Li-Chun; MIN-SHU HSIEH; CHIH-HUNG HSU; Shao, Yu-Yun; Lee, Yi-Hsuan; HSIANG-FONG KAO; Yu-Yun Shao; Hsieh, Min-Shu; ANN-LII CHENG; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; Lu, Li-Chun;Shao, Yu-Yun;Lee, Yi-Hsuan;Hsieh, Min-Shu;Hsiao, Chi-Huang;Lin, Hsiao-Hui;Kao, Hsiang-Fong;Ma, Yu-Yi;Yen, Feng-Chu;Cheng, Ann-Lii;Hsu, Chih-Hung; Lu, Li-Chun and Shao, Yu-Yun and Lee, Yi-Hsuan and Hsieh, Min-Shu and Hsiao, Chi-Huang and Lin, Hsiao-Hui and Kao, Hsiang-Fong and Ma, Yu-Yi and Yen, Feng-Chu and Cheng, Ann-Lii and Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T08:15:22Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao, Y.-Y. and Kuo, K.-T. and Hu, F.-C. and Lu, Y.-S. and Huang, C.-S. and Liau, J.-Y. and Lee, W.-C. and Hsu, C. and Kuo, W.-H. and Chang, K.-J. and Lin, C.-H. and Cheng, A.-L.; CHIUN-SHENG HUANG; Yu-Yun Shao; JAU-YU LIAU; CHING-HUNG LIN; KUAN-TING KUO; ANN-LII CHENG |
| 臺大學術典藏 |
2018 |
A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma
|
Yang S.-H.;Yu-Yun Shao;Lin C.-C.;Kuo S.-H.;Cheng A.-L.;Yeh K.-H.; Yang S.-H.; YU-YUN SHAO; Lin C.-C.; Kuo S.-H.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2017 |
High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma
|
Hsu C.-H.; Chen H.-M.; Cheng A.-L.; Lee Y.-H.; Li Y.-S.; Yu-Yun Shao;Lin H.;Li Y.-S.;Lee Y.-H.;Chen H.-M.;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO; Lin H. |
| 臺大學術典藏 |
2017 |
National policies fostering hospice care increased hospice utilization and reduced the invasiveness of end-of-life care for cancer patients
|
Yu-Yun Shao;Hsiue E.H.-C.;Hsu C.-H.;Yao C.-A.;Chen H.-M.;Lai M.-S.;Cheng A.-L.; YU-YUN SHAO; Hsiue E.H.-C.; Hsu C.-H.; Yao C.-A.; Chen H.-M.; Lai M.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2016 |
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study
|
Chen K.-H.; YU-YUN SHAO; Chen H.-M.; Lin Y.-L.; Lin Z.-Z.; Lai M.-S.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2014 |
Clinical activity of metronomic chemotherapy in liver cancers
|
Hsu C.-H.; Cheng A.-L.; Yu-Yun Shao;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO |
| 臺大學術典藏 |
2013 |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
YU-YUN SHAO; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lin Z.-Z. |
显示项目 101-110 / 113 (共12页)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每页显示[10|25|50]项目
|
